Sort
15,273 grants matching “antimicrobial resistance”
Selective proteasome inhibitors for trichomoniasis
$236,250Lars Eckmann · University Of California, San Diego · R21 · FY2019 · AI
Diversity of Antimicrobial Use and Emergence of Resistance in Pseudomonas
$236,250Darren R Linkin · University Of Pennsylvania · R21 · FY2007 · AI
Surface dependent inhibition of Mycobacterium abscessus by Pseudomonas aeruginosa
$236,250Daniel J Wozniak · Ohio State University · R21 · FY2024 · AI
Innate Resistance to Mucosal HSV Infection in Humans
$236,186Christine M Posavad · Fred Hutchinson Cancer Research Center · R21 · FY2009 · AI
Quantitative analysis of the evolving genotype-to-phenotype map
$236,133Daniel Jarosz · Stanford University · R00 · FY2015 · GM
Computational Modeling /Design of Antimicrobial Peptides
$236,124University Of Minnesota Twin Cities · R01 · FY2005 · GM
Targetting InhA For Anti-TB Drug Discovery
$236,122Peter J Tonge · State University New York Stony Brook · R01 · FY2006 · AI
The Great Diseases: Bridging biomedical career exploration, competency building and mentoring
$236,113Berri H Jacque · Tufts University Boston · R25 · FY2023 · GM
Bacterial Evasion of Innate Defenses at the Ocular Surface
$236,096Daria N Van Tyne · University Of Pittsburgh At Pittsburgh · R00 · FY2020 · EY
Identifying polyamine dependent mechanisms in pneumococcal pneumonia
$236,057Bindu Nanduri · Mississippi State University · P20 · FY2015 · GM
Development of an Oral Carbapenem Drug for Treatment of Drug Resistant TB
$236,056Gyanu Lamichhane · Johns Hopkins University · R21 · FY2014 · AI
How group A Streptococcus M1 protein resists cathelicidins
$236,000Partho Ghosh · University Of California, San Diego · R21 · FY2019 · AI
Metabolome-Based Biomarkers and Neutraceuticals in Clostridium Difficile Infection
$235,950Tor C. Savidge · Baylor College Of Medicine · R21 · FY2014 · DK
Development of therapeutic bacteriophages against carbapenemase-resistant Klebsiella pneumoniae
$235,888Jason J. Gill · Texas A&M Agrilife Research · R21 · FY2017 · AI
Virulence-conferring siderophore biosynthesis inhibitors
$235,888Luis E Quadri · Weill Medical Coll Of Cornell Univ · R21 · FY2006 · AI
The Role of Lipoarabinomannan in Mycobacterium tuberculosis
$235,800Tanya Parish · Access To Advanced Health Institute · R21 · FY2009 · AI
Allosteric Modulation of the Multidrug Transporter MDR1
$235,778Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2005 · GM
Allosteric Modulation of the Multidrug Transporter MDR1
$235,778Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2004 · GM
Structural Dynamics of Multi-drug Transporters
$235,769Hassane S McHaourab · Vanderbilt University · R01 · FY2022 · GM
Structural Dynamics of Multi-drug Transporters
$235,769Hassane S McHaourab · Vanderbilt University · R01 · FY2023 · GM
A Novel Self-Renewing Heparin-Binding Anti-microbial Device Surface Coating
$235,750David W Grainger · University Of Utah · R21 · FY2010 · DK
Identification of new or unrecognized virulence genes in hypervirulent Klebsiella pneumoniae and antivirulence genes in classical K. pneumoniae.
$235,744Thomas A Russo · State University Of New York At Buffalo · R21 · FY2021 · AI
Structural Dynamics of Multi-drug Transporters
$235,583Hassane S McHaourab · Vanderbilt University · R01 · FY2021 · GM
Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae
$235,518Robert A. Bonomo · Case Western Reserve University · R21 · FY2016 · AI
Role of NRAMP1/SLC11A1 in Salmonella pathogenesis
$235,500Renee M. Tsolis · University Of California At Davis · R21 · FY2019 · AI